why choose us

First received: June 20, 2023

Clinical Trial: A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Adults

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effect of a Breast Cancer Resistance Protein Inhibitor on the Single-dose Pharmacokinetics of Adagrasib in Healthy Adult Subjects

Brief Summary: A Phase 1, Open-label, One-sequence Crossover Study to Investigate the Effect of a Breast Cancer Resistance Protein Inhibitor on the Single-dose Pharmacokinetics of Adagrasib in Healthy Adult Subjects

Read more